Lv1
100 积分 2025-12-24 加入
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
12天前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
12天前
已完结
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant
12天前
已完结
Advances in understanding cisplatin-induced toxicity: Molecular mechanisms and protective strategies
12天前
已完结
Chinese herbal medicine for irinotecan-induced diarrhea: A systematic review and meta-analysis
2个月前
已完结
Effectiveness and safety of serplulimab plus platinum-based chemotherapy in first-line treatment of extensive-stage small cell lung cancer liver metastases: a retrospective cohort study
2个月前
已完结
Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer
2个月前
已完结
The current and emerging immunotherapy paradigm in small-cell lung cancer
2个月前
已完结
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer
2个月前
已完结
Mechanisms and emerging strategies for irinotecan-induced diarrhea
3个月前
已完结
皖公网安备34019202002308
